The Methylprednisolone Market is expected to grow at a significant CAGR during the forecast period (2021-2027). It is a corticosteroid drug that is used to control inflammatory immunological responses. It's used to treat inflammatory illnesses including lupus, arthritis, psoriasis, ulcerative colitis, gland abnormalities, and skin, lungs, stomach, and nervous system issues. The drug can be taken orally or injected into a vein or muscle. When a comparable medication cannot be taken by mouth or when a rapid response is required, such as in individuals with severe medical problems, an injectable version of methylprednisolone is utilized.

The global methylprednisolone market is projected to be driven by an increase in the prevalence of chronic diseases and occurrences of a variety of medical conditions such as brain tumours and skin diseases, as well as technical advancements in drug discovery and development procedures.

The skin care segment is expected to dominate the market during the forecast period due to a range of applications of corticosteroids in the treatment of skin diseases like rash, dermatitis, itching, eczema and psoriasis, which are common in rising the rising geriatric population. The increased storage capacity of topical corticosteroids is also expected to drive market growth. Because age causes the normal functioning of organ systems, including the skin. The elderly population is particularly vulnerable to skin disorders. The geriatric population with skin problems prefers oral corticosteroid treatment because it is more convenient.

Methylprednisolone was authorised by the FDA on October 24, 1957. Moreover, the efficiency of a low dose methylprednisolone treatment in COVID-19 has been proved during the pandemic. Clinical studies are being conducted to see how effective methylprednisolone is in treating new coronavirus pneumonia. Thus, the use of methylprednisolone in the treatment of COVID-19 is driving market growth in recent times.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Type 

o By Application 

• Regions Covered

o North America

o Europe

o Asia-Pacific

o Rest of the world

• Competitive Landscape: Endo International Plc, Jubilant Cadista, Teva Pharmaceuticals, Tianjin Kingyork, Pfizer Inc.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Methylprednisolone Market by Segments 

By Type

• Infusion (Intravenous)
• Oral

By Application

• Hospitals
• Drug Store
• R&D Institutes

Global Methylprednisolone Market by Region